title: Increased bone formation using calcium sulfate-calcium phosphate composite graft.
abstract: Calcium phosphates (CaPO4) and faster-resorbing calcium sulfate (CaSO4) are successfully employed as synthetic bone grafts for treatment of contained defects. We used a canine critical-sized bone defect model to study an injectable CaSO4/CaPO4 composite graft that incorporated a matrix of CaSO4 and dicalcium phosphate dihydrate into which beta-tricalcium phosphate granules were distributed. The area fraction, ultimate compressive stress, and elastic modulus of restored bone and the relative rates of material resorption were compared between the CaSO4/CaPO4 composite graft and pure CaSO4 pellets and to normal canine bone. The area fraction of bone in stained sections and the ultimate compressive stress of the regenerated bone were greater using the CaSO4/CaPO4 composite graft compared to pure CaSO4 pellets after 13 and 26 weeks and were greater than normal bone. The elastic modulus of restored bone in defects treated with CaSO4/CaPO4 composite graft was greater than in defects treated with CaSO4 pellets after 26 weeks, but similar to specimens of normal bone. A small amount of CaSO4/CaPO4 composite graft and no CaSO4 pellets remained after 13 or 26 weeks. This novel CaSO4/CaPO4 composite holds promise for clinical applications where a strong, injectable, slower-resorbing, and biocompatible bone graft substitute would be advantageous.
authors.affiliation: Department of Orthopedic Surgery, Rush University Medical Center, Chicago, IL 60612, USA. robert_urban@rush.edu
authors.forename: Robert M
authors.initials: RM
authors.lastname: Urban
authors.forename: Thomas M
authors.initials: TM
authors.lastname: Turner
authors.forename: Deborah J
authors.initials: DJ
authors.lastname: Hall
authors.forename: Nozomu
authors.initials: N
authors.lastname: Inoue
authors.forename: Steven
authors.initials: S
authors.lastname: Gitelis
mesh_terms: D000818:Animals; D018786:Bone Substitutes / Q000008:administration & dosage / Q000493:pharmacokinetics*; D002130:Calcium Phosphates / Q000008:administration & dosage / Q000493:pharmacokinetics*; D002133:Calcium Sulfate / Q000008:administration & dosage / Q000493:pharmacokinetics*; D019245:Compressive Strength; D004285:Dogs; D004548:Elasticity; D005269:Femur / Q000187:drug effects* / Q000378:metabolism / Q000503:physiopathology; D007267:Injections; D008297:Male; D010012:Osteogenesis / Q000187:drug effects*
chemical_list: D018786:Bone Substitutes; D002130:Calcium Phosphates; C485817:beta-tricalcium phosphate; C494366:calcium phosphate, dibasic, dihydrate; D002133:Calcium Sulfate